![conference banner](/images/conference-banner.jpeg)
Abstract
In the pathogenesis of asthma, chronic inflammation within the airways plays a major role. Corticosteroids (or glucocorticosteroids) have beneficial anti-inflammatory effects and are recommended in all international guidelines for treating asthmatic inflammation. However, control remains difficult for almost 5% of asthmatics despite high doses of inhaled corticosteroids. Several classes of difficult asthma have been described: "brittle asthma", "steroid-resistant asthma", "steroid-dependent asthma", and "refractory asthma", and used interchangeably. Some hypotheses have been posed regarding the pathogenesis of difficult/therapy resistant asthma. Recent studies indicate that steroid-resistant asthma is associated with a failure of corticosteroids to inhibit T-lymphocyte proliferation and secretion or their cytokines. In cases of severe asthma, sputum and tissue eosinophilia vary from "normal" to "elevated" levels, and increased numbers of neutrophils are common. It also appears that conditional to a poor response to the treatment with corticosteroids are the abnormalities in glucocorticoid receptor (GR) number, GR binding, or corticosteroid-GR complex binding to DNA. The causes and predictors of difficult asthma are still uncertain. One predicting possibility is tobacco smoke. Smoking induces the release of interleukin-8, which is the potent neutrophil chemoattractant. Further research is required to clarify the exact mechanisms in difficult/therapy-resistant asthma, and to develop an optimal treatment approaches.
Keywords: Asthma, pathogenesis, therapy resistance, smoking
Current Respiratory Medicine Reviews
Title: Difficult/Therapy-Resistant Asthma: Pathogenesis and Possible Relationship with Tobacco Smoke
Volume: 2 Issue: 1
Author(s): Brigita Sitkauskiene, Algirda Krisiukeniene and Raimundas Sakalauskas
Affiliation:
Keywords: Asthma, pathogenesis, therapy resistance, smoking
Abstract: In the pathogenesis of asthma, chronic inflammation within the airways plays a major role. Corticosteroids (or glucocorticosteroids) have beneficial anti-inflammatory effects and are recommended in all international guidelines for treating asthmatic inflammation. However, control remains difficult for almost 5% of asthmatics despite high doses of inhaled corticosteroids. Several classes of difficult asthma have been described: "brittle asthma", "steroid-resistant asthma", "steroid-dependent asthma", and "refractory asthma", and used interchangeably. Some hypotheses have been posed regarding the pathogenesis of difficult/therapy resistant asthma. Recent studies indicate that steroid-resistant asthma is associated with a failure of corticosteroids to inhibit T-lymphocyte proliferation and secretion or their cytokines. In cases of severe asthma, sputum and tissue eosinophilia vary from "normal" to "elevated" levels, and increased numbers of neutrophils are common. It also appears that conditional to a poor response to the treatment with corticosteroids are the abnormalities in glucocorticoid receptor (GR) number, GR binding, or corticosteroid-GR complex binding to DNA. The causes and predictors of difficult asthma are still uncertain. One predicting possibility is tobacco smoke. Smoking induces the release of interleukin-8, which is the potent neutrophil chemoattractant. Further research is required to clarify the exact mechanisms in difficult/therapy-resistant asthma, and to develop an optimal treatment approaches.
Export Options
About this article
Cite this article as:
Sitkauskiene Brigita, Krisiukeniene Algirda and Sakalauskas Raimundas, Difficult/Therapy-Resistant Asthma: Pathogenesis and Possible Relationship with Tobacco Smoke, Current Respiratory Medicine Reviews 2006; 2 (1) . https://dx.doi.org/10.2174/157339806775486173
DOI https://dx.doi.org/10.2174/157339806775486173 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Chronic obstructive pulmonary disease (COPD) from childhood to adulthood: from the past to the future
Chronic obstructive pulmonary disease (COPD) is one of the three leading causes of death worldwide, with a major prevalence in low- and middle-income countries, resulting in a high social and economic cost. It is a heterogeneous respiratory disease, treatable and preventable, that causes persistent and often progressive airway obstruction in ...read more
![Wayfinder Image](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Hypotensive Peptides from Snake Venoms: Structure, Function and Mechanism
Current Topics in Medicinal Chemistry Antioxidative Properties of Flavonoids
Current Organic Chemistry Polymorphisms in TOLL-Like Receptor Genes and their Roles in Allergic Asthma and Atopy
Recent Patents on Inflammation & Allergy Drug Discovery Heteromerization of G Protein-Coupled Receptors: Relevance to Neurological Disorders and Neurotherapeutics
CNS & Neurological Disorders - Drug Targets Polymorphism in Endothelin-1 Gene: An Overview
Current Clinical Pharmacology Multiple Drug Intolerance Syndrome: An Underreported Distinct Clinical Entity
Current Clinical Pharmacology Features of the Course of COVID-19 in Health Care Workers of a Non-infectious Hospital
Current Respiratory Medicine Reviews CD4+CD25+ Regulatory T-Cell Therapy for Allergy, Autoimmune Disease and Transplant Rejection
Inflammation & Allergy - Drug Targets (Discontinued) Genus <i>Acronychia</i>: An Extensive Review on Phytochemistry and Pharmacological Activities
Mini-Reviews in Organic Chemistry Informing People about the Risks and Benefits of Medicines: Implications for the Safe and Effective Use of Medicinal Products
Current Drug Safety Recent Patents on the Treatment of Type 1 Diabetes
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Recent Advances in Liposomal Drug Delivery: A Review
Pharmaceutical Nanotechnology Mast Cells as Critical Effectors of Host Immune Defense against Gram-negative Bacteria
Current Medicinal Chemistry A Timely Review of State-of-the-Art Chronopharmaceuticals Synchronized with Biological Rhythms
Current Drug Delivery Recurrent Wheezing in a Child: Unraveling Atypical Presentations of Cystic Fibrosis and Polymorphisms: A Case Report
Current Respiratory Medicine Reviews Diagnostics and Therapy of Antineutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitides
Current Pharmaceutical Design Immunomodulatory Effect of Cytokines in the Differentiation of Mesenchymal Stem Cells: A Review
Current Stem Cell Research & Therapy Characterization of Phosphorylated Proteins Using Mass Spectrometry
Current Protein & Peptide Science Crosstalk Between Histamine and T Cells in Allergic Diseases
Current Immunology Reviews (Discontinued) The Role of Metabolism in Toxicity of Polycyclic Aromatic Hydrocarbons and their Non-genotoxic Modes of Action
Current Drug Metabolism